NCT05813288: An ongoing trial by Areteia Therapeutics
This trial is ongoing. It must report results 7 months, 3 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05813288 |
|---|---|
| Title | A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of Dexpramipexole Administered Orally for 52 Weeks in Participants With Severe Eosinophilic Asthma |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 27, 2023 |
| Completion date | Dec. 8, 2025 |
| Required reporting date | Dec. 8, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | April 17, 2026 |
| Days late | None |